JP Morgan Upgrades Bioventus to Neutral, Raises Price Target to $13

BenzingaDec 17 07:16 ET · Ratings

Bioventus: Strategic Moves Amidst Financial Challenges Justify Hold Rating

TipRanksDec 17 05:36 ET · Ratings

J.P. Morgan Upgrades Bioventus(BVS.US) to Hold Rating, Raises Target Price to $13

Moomoo NewsDec 17 05:34 ET · Ratings

Express News | Bioventus Inc : JP Morgan Raises to Neutral From Underweight; Raises Target Price to $13 From $12

ReutersDec 17 00:29 ET

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

Yahoo FinanceDec 6 09:55 ET

Earnings Call: Bioventus Reports Robust Q3 Growth, Raises Full-year Guidance

InvestingNov 6 13:24 ET